Johnson & Johnson’s experimental Covid-19 vaccine induced immune responses in most people who received the shot in a small early-stage trial, and also displayed an acceptable safety profile, according to a study posted online Friday. The findings added more detail to J&J’s announcement earlier this week that the results from the Phase 1/2 trial were positive, and mean the vaccine, one of the leading candidates in development, has taken another step toward proving whether it works safely.

Source: Wall Street Journal September 25, 2020 19:21 UTC